Menu
Washingtoner
  • Home
  • Health
  • Boeing
  • Daryl Guberman
  • Aerospace
  • Technology
  • Business
  • Artificial Intelligence
  • ANSI-ANAB
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • KLEKT Announces Appointment of Jay Kimpton to Board of Directors
  • Tacoma City Council Restricts Unauthorized Use of Public Property for Civil Immigration Enforcement
  • The Simplest Small Business You're Probably Not Thinking About
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • FutureLot Powers ADU Wizard for Massachusetts Clean Energy Center's Statewide ADU Resource Center
  • ICT Innovations Releases ICTPBX Community Edition as Open Source Under Mozilla Public License 2.0
  • Spokane: City Closures Planned for Memorial Day
  • Spokane: Child Injured in Basement Fire Reminds About Youth Fire Setting
  • Maryland Personal Injury Firm Earns National Recognition in 2026 ELA Awards

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
  • AI Predicts the Most Likely 2026 FIFA World Cup Winner
  • The AI Production Shift: Why Game Development Is Entering Its Most Accelerated Phase
  • World-First AI Humanoid Robot Debuts on Cherie Barber's Ground-breaking Australian Reno Show
  • New Survey Reveals America's Most Feared Bridges for Cyclists — Golden Gate Tops the List
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
  • NaturismRE Launches Structured Nudism & Naturism Encyclopedia, Aiming to Reframe Public Understanding
  • AI Is Closing the Gap Between Offshore Virtual Assistants and Onshore Staff
  • CCHR Highlights Concerns Over Coercive and Failed $140 Billion Mental Health Practices at Psychiatric Convention
  • Avery Headley Leads Major Stabilization and Modernization Initiative Across Bronx Affordable Housing Portfolio
  • Tacoma: City Council Takes Steps to Further Activate and Support High-Investment Corridors
  • NewReputation's AI Sentiment Analysis Tool Reaches 2,500 Users as Businesses Demand Clearer Brand Intelligence
  • CAPO Supply Announces Opening of Second Location in New Castle, Pennsylvania
  • $224 Billion Growing Market in Life Settlements Presents Major Opportunity for New Policy Acquisition Business Plan: DLT Resolution Stock Symbol: DLTI
  • Fyt-02 Launches on Kickstarter The Smart Sensor That Turns Any Chair Into a Posture & Movement Track
  • YieldOMega Launches $DOUB Airdrop Campaign Ahead of TimeCurve Launch
  • Kaltra Expands Microchannel Water Coil Line for U.S. HVAC Market With New Corrosion-Resistant Tube Technology
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • Phoenix Hip-hop Artist Rhymi Hits 23k Monthly Listeners 12 Days After Album Release
  • Pediatrician Launches "Confessions of a Detective Doctor" Children's Book Series
_catLbl0 _catLbl1

Popular on Washingtoner

  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
  • Freedomtech Solutions creates 'Global Data Centre Network (IDCN)'
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • New Report Reveals Plane Crashes Are Not Where You'd Think
  • City Council Adopts Updated Resolution for ‘Connect Tacoma’ Ballot Proposition
  • L2 Aviation Acquires Advance Aero
  • Axencis Launches Performance Partnership for Brand Protection
  • Tacoma: Pothole Palooza Returns May 4 – 15 to Focus on Maintenance and Preservation of 10 Arterial Roadways
  • Project Pretzel Introduces a New System for Running Renovation Projects with Built In Contracts and Real Time Execution

Similar on Washingtoner

  • Lick Introduces Pineapple Flavored Massage Oil — A Tropical Date Night Favorite Available on Amazon
  • Bangxing Silicone Revolutionizes Silicone Baby Product Partnerships: Low MOQ Support + VIP Long-Term Win-Win Programs
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
  • NaturismRE Launches Structured Nudism & Naturism Encyclopedia, Aiming to Reframe Public Understanding
  • CCHR Highlights Concerns Over Coercive and Failed $140 Billion Mental Health Practices at Psychiatric Convention
  • Fyt-02 Launches on Kickstarter The Smart Sensor That Turns Any Chair Into a Posture & Movement Track
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • Pediatrician Launches "Confessions of a Detective Doctor" Children's Book Series
  • All About Technology Celebrates 25 Years of Bridging Detroit's Digital Divide
  • iatroX surpasses 500,000 clinical queries and expands specialist exam coverage
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute